3rd Quarter - Report

VAN HEUVELEN STRATEGIES, LLC for ALLERGAN PLC (FORMERLY KNOWN AS ACTAVIS)

Period 3rd Quarter 2015 Filed Oct 20, 2015 Signed by Robert Van Heuvelen

Official filing

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
VAN HEUVELEN STRATEGIES, LLC
Client
ALLERGAN PLC (FORMERLY KNOWN AS ACTAVIS)
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 20, 2015 $60,000 Replaced
3rd Quarter - Amendment Jan 21, 2016 $60,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues related to the Prescription Drug User Fee Act. Issues related to generic prescription drug prices and other issues related to generic drugs. Issues related to patent reform. Issues related to international taxes. H.R. 6 - 21st Century Cures Act H.R. 9 - Innovation Act H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 2045 - Targeting Rogue and Opaque Letters (TROL) Act S. 632 - Supporting Technology and Research for Our Nation's Growth (STRONG) Patents Act S. 1137 Protecting American Talent and Entrepreneurship Act of 2015 or PATENT Act

LobbyistCovered position, as disclosed
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad
STEPHEN DOUGLAS WARD Chief of Staff to Senator Jeff Bingaman

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2 (114th), H.R. 6 (114th), H.R. 9 (114th), H.R. 2045 (114th), S. 632 (114th), S. 1137 (114th)

Copyright/Patent/Trademark CPT

Issues related to the Prescription Drug User Fee Act. Issues related to generic prescription drug prices and other issues related to generic drugs. Issues related to patent reform. Issues related to international taxes. H.R. 6 - 21st Century Cures Act H.R. 9 - Innovation Act H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 2045 - Targeting Rogue and Opaque Letters (TROL) Act S. 632 - Supporting Technology and Research for Our Nation's Growth (STRONG) Patents Act S. 1137 Protecting American Talent and Entrepreneurship Act of 2015 or PATENT Act

LobbyistCovered position, as disclosed
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad
STEPHEN DOUGLAS WARD Chief of Staff to Senator Jeff Bingaman

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th), H.R. 2045 (114th), S. 1137 (114th), H.R. 2 (114th), H.R. 9 (114th), S. 632 (114th)

Health Issues HCR

Issues related to the Prescription Drug User Fee Act. Issues related to generic prescription drug prices and other issues related to generic drugs. Issues related to patent reform. Issues related to international taxes. H.R. 6 - 21st Century Cures Act H.R. 9 - Innovation Act H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 2045 - Targeting Rogue and Opaque Letters (TROL) Act S. 632 - Supporting Technology and Research for Our Nation's Growth (STRONG) Patents Act S. 1137 Protecting American Talent and Entrepreneurship Act of 2015 or PATENT Act

LobbyistCovered position, as disclosed
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad
STEPHEN DOUGLAS WARD Chief of Staff to Senator Jeff Bingaman

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 632 (114th), H.R. 9 (114th), H.R. 2 (114th), H.R. 2045 (114th), H.R. 6 (114th), S. 1137 (114th)

Labor Issues/Antitrust/Workplace LBR

Issues related to the Prescription Drug User Fee Act. Issues related to generic prescription drug prices and other issues related to generic drugs. Issues related to patent reform. Issues related to international taxes. H.R. 6 - 21st Century Cures Act H.R. 9 - Innovation Act H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 2045 - Targeting Rogue and Opaque Letters (TROL) Act S. 632 - Supporting Technology and Research for Our Nation's Growth (STRONG) Patents Act S. 1137 Protecting American Talent and Entrepreneurship Act of 2015 or PATENT Act

LobbyistCovered position, as disclosed
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad
STEPHEN DOUGLAS WARD Chief of Staff to Senator Jeff Bingaman

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2045 (114th), H.R. 2 (114th), S. 632 (114th), S. 1137 (114th), H.R. 6 (114th), H.R. 9 (114th)

Budget/Appropriations BUD

Issues related to the Prescription Drug User Fee Act. Issues related to generic prescription drug prices and other issues related to generic drugs. Issues related to patent reform. Issues related to international taxes. H.R. 6 - 21st Century Cures Act H.R. 9 - Innovation Act H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 2045 - Targeting Rogue and Opaque Letters (TROL) Act S. 632 - Supporting Technology and Research for Our Nation's Growth (STRONG) Patents Act S. 1137 Protecting American Talent and Entrepreneurship Act of 2015 or PATENT Act

LobbyistCovered position, as disclosed
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad
STEPHEN DOUGLAS WARD Chief of Staff to Senator Jeff Bingaman

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1137 (114th), H.R. 9 (114th), H.R. 6 (114th), H.R. 2 (114th), S. 632 (114th), H.R. 2045 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.